Global Vaccines Market Industry Outlook, Comprehensive Insights, Growth and Forecast 2028||Bio Farma, Emergent BioSolutions Inc., Dynavax Technologies, Valneva SE, Bavarian Nordic, Altimmune, Merck Sharp & Dohme Corp

The persuasive Vaccines market report considers important aspects of the market that consist of historic data, present market trends, environment, technological innovation, upcoming technologies and the technical progress in the pharmaceutical industry. It makes effortless for pharmaceutical industry to visualize what is already available in the market, what market anticipates, the competitive environment, and what should be done to surpass the competitor. This market report lends a hand to stay up-to-date about the whole market and also brings into light holistic view of the market. The wide ranging Vaccines market research report is truly a backbone for every business with which they can not only grow sales but also prosper in the market.

The vaccines market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 6.9% in the forecast period of 2021 to 2028 and is expected to reach USD 61,988.47 million by 2028. Growing immunization programs and campaigns and high prevalence of chronic conditions such as flu and bacterial infectious diseases are the major drivers which has propelled the demand of the vaccines market in the forecast period.

Get Full PDF Sample Copy of Report:

The major companies which are dealing in the global vaccines market report are Bharat Biotech, Biological E Limited, Bio Farma, Emergent BioSolutions Inc., Dynavax Technologies, Valneva SE, Bavarian Nordic, Altimmune, Merck Sharp & Dohme Corp. (a subsidiary of Merck & Co., Inc.), Takeda Pharmaceutical Company Limited, Seqirus (a subsidiary of CSL Limited), Abbott, AstraZeneca, Sanofi, Pfizer Inc., Janssen Global Services, LLC (a subsidiary of Johnson & Johnson Services, Inc.), F. Hoffmann-La Roche Ltd, DAIICHI SANKYO COMPANY, LIMITED, ALK, Panacea Biotec Ltd, BAXTER VACCINES (a subsidiary of Baxter), GlaxoSmithKline plc, Lanzhou Biological Products Research Institute Co., Ltd., Serum Institute of India Pvt. Ltd. among other global and domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product launches and agreements are also initiated by the companies’ worldwide which are also accelerating the vaccines market.

For instance,

  • In November 2020, GlaxoSmithKline plc along with Medicines for Malaria Venture presented a positive data (TEACH study) of tafenoquine used for the treatment of Plasmodium vivax malaria in children and adolescents. During the four months of examination, 95% of studied 60 subjects that did not show the signs of Plasmodium vivax malaria. The results were presented through virtual annual meeting of American Society of Tropical Medicine & hygiene 2020. This has helped the company to move forward on the product for the treatment of malaria and to provide the evidence of their product.

New Market Development

  • In June 2020, Merck Sharp & Dohme Corp. (a subsidiary of Merck & Co., Inc.) received approval for gardasil 9 (HPV 9 –valent recombinant vaccine) for prevention of HPV related cervical, vaginal, vulvar, anal, oropharyngeal and other neck and head cancers. HPV related cancers are common in both men and women, hence targeting a large population size. This approval has enhanced the company’s product portfolio and allowed it to generate more revenue.

Scope of the Global Vaccines Market

Global vaccines market is segmented on the basis of countries into the U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, rest of Europe, Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Vietnam, rest of Asia-Pacific, Brazil, Argentina, Peru, rest of South America, Saudi Arabia, South Africa, UAE, Israel, Kuwait, Egypt and rest of Middle East and Africa.

  • All country based analysis of the global vaccines market is further analyzed based on maximum granularity into further segmentation. On the basis of composition, the vaccines market is segmented into combination vaccines, monovaccines. On the basis of type, the vaccines market is segmented into subunit, recombinant, polysaccharide and conjugate vaccines, live-attenuated vaccines, inactivated vaccines, toxoid vaccines and DNA vaccines. On the basis of kind, the vaccines market is segmented into routine vaccine, recommended vaccine and required vaccine. On the basis of age of administration, the vaccines market is segmented into pediatric vaccine and adult vaccine. On the basis of diseases, the vaccines market is segmented into pneumococcal disease, measles, mumps & varicella, DPT, hepatitis, influenza, typhoid, meningococcal, rabies, Japanese encephalitis, yellow fever and others. On the basis of route of administration, the vaccines market is segmented into injectable, oral and nasal. On the basis of end user, the vaccines market is segmented into community hospitals, hospitals, specialty centres, clinics and others. On the basis of distribution channel, the vaccines market is segmented into hospital pharmacy, retail pharmacy and online pharmacy.

Enquire Here Get customization & check discount for report @:

Trends Impacting the Vaccines Market

Now the question is which other regions GlaxoSmithKline plc, Merck Sharp & Dohme Corp. (a subsidiary of Merck & Co., Inc.) and Sanofi are targeting? Data Bridge Market Research has forecasted a large growth in North America vaccines market and the market leaders targeting the U.S. and Canada to be their next revenue pockets for 2021.

The vaccines market is becoming more competitive with companies such as GlaxoSmithKline plc, Merck Sharp & Dohme Corp. (a subsidiary of Merck & Co., Inc.) and Sanofi as they are the top dominating companies in vaccines market and are launching more new therapies in the market. The Data Bridge Market Research new reports highlight the major growth factors and opportunities in the global vaccines market.

Objectives of Vaccines report:

  1. To make available the wide-ranging overview of the Vaccines market.
  2. To achieve the information about the key players in this industry, their product portfolios, and their key strategies.
  3. To be aware of the future outlook and prospects for Vaccines market analysis and forecast 2021-2028.
  4. To analyze the market size of the market so that understanding the key trends from it gets easy.
  5. To examine the market based on product, market share, and size of the product share.
  6. To analyze prospects or opportunities in the market for stakeholders by knowing the high-growth segments of the Vaccines market.
  7. To gain insights about the major regional insights in which the Vaccines is flourishing.
  8. To achieve illustrations and forecast the Vaccines market, in terms of value, by process, product type, and industry.
  9. To tactically outline the major players and comprehensively analyze their market position in terms of ranking and core competencies, and detail the competitive landscape for market leaders.
  10. To describe and forecast the market, in terms of value, for various segments, by region North America, Europe, Asia Pacific (APAC), and Rest of the World (RoW).

Get detailed toc @

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing . We are content with our glorious 99.9 % client satisfying rate.


Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475



Related Articles

Back to top button